<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01821989</url>
  </required_header>
  <id_info>
    <org_study_id>moos80</org_study_id>
    <nct_id>NCT01821989</nct_id>
  </id_info>
  <brief_title>Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm Neonate</brief_title>
  <official_title>Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm Neonate.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mooselmokadem</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mooselmokadem</source>
  <brief_summary>
    <textblock>
      Hypothesis:

      Orally ingested lactoferrin has effects on promotion of growth and differentiation of the
      immature gut; also it has immunomodulatory properties, so it will prevent serious infections
      in preterm infants.

      The aim of the study is to:

        -  Evaluate the effectiveness of oral lactoferrin in prevention of neonatal sepsis.

        -  Compare two dose regiment of lactoferrin supplementation.

        -  Study effect of lactoferrin supplementation on serum iron stores.

      It is a prospective, randomized, double blind, placebo-controlled study, it will include 180
      preterm neonates admitted to the Neonatal Intensive Care Units of of Ain Shams University
      Hospitals and Manshiet El Bakry Hospital.

      •Group A: Who will receive oral lactoferrin supplementation in a dose of 100 mg/day.

      •Group B: Who will receive oral lactoferrin supplementation in a dose of 150 mg/kg/ twice
      daily.

      •Group C (Controls): Who match the subjected neonates, will receive placebo in form of
      distilled water.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood culture</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete blood count with differential leucocytic count.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>C reactive protein quantitative assay</measure>
    <time_frame>2 years</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Neonatal Sepsis</condition>
  <arm_group>
    <arm_group_label>Low Dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactoferrin,dose of 100 mg/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lactoferrin, dose of 150 mg/kg/ twice daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Receive placebo in form of distilled water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactoferrin</intervention_name>
    <description>dose of 100 mg/day</description>
    <arm_group_label>Low Dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactoferrin</intervention_name>
    <description>dose of 150 mg/kg/ twice daily</description>
    <arm_group_label>High Dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>in form of distilled water</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Neonates with a birth weight between 500g and 2500g.

          2. Neonates with a ≤ 36 weeks of gestation counting from the first day of the Last
             Menstrual Period.

          3. Preterm neonates born in, or referred to the Neonatal Intensive Care Units of one of
             the participating hospitals in the first 48 hours of life.

        Exclusion Criteria:

          1. Neonates with underlying gastrointestinal problems that prevent oral intake.

          2. Neonates with predisposing conditions that profoundly affect growth and development
             (chromosomal abnormalities, structural brain anomalies, severe congenital
             abnormalities).

          3. Neonates with a family background of cow milk allergy.

          4. Neonates who will not have the chance to complete the study time (who will be referred
             to another hospitals).

          5. Neonates whose parents decline to participate.

          6. Neonates with early onset sepsis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mostafa AM Elmokadem, Master</last_name>
    <phone>01110857100</phone>
    <phone_ext>02</phone_ext>
    <email>drmooselmokadem@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <state>Abassia</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2013</study_first_submitted>
  <study_first_submitted_qc>March 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2013</study_first_posted>
  <last_update_submitted>May 8, 2014</last_update_submitted>
  <last_update_submitted_qc>May 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mooselmokadem</investigator_affiliation>
    <investigator_full_name>Mostafa El-Mokadem</investigator_full_name>
    <investigator_title>neonatologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactoferrin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

